Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation
Shihao Zheng,
Wenying Qi,
Tianyu Xue,
Xiaobin Zao,
Jinchi Xie,
Peng Zhang,
Xiaoke Li,
Yongan Ye,
Aimin Liu
Affiliations
Shihao Zheng
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China; Beijing University of Chinese Medicine, Beijing, 100102, China
Wenying Qi
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China; Beijing University of Chinese Medicine, Beijing, 100102, China
Tianyu Xue
Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, 050000, China
Xiaobin Zao
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China
Jinchi Xie
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China
Peng Zhang
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China
Xiaoke Li
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China; Liver Diseases Academy of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; Corresponding author. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China.
Yongan Ye
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China; Liver Diseases Academy of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; Corresponding author. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China.
Aimin Liu
Shangzhuang Township Community Health Service Center, Beijing, 100094, China; Corresponding author. Shangzhuang Township Community Health Service Center, Beijing, 100094, China.
Chronic hepatitis B (CHB) is a chronic inflammatory disease of the liver caused by infection with the hepatitis B virus (HBV), which in later stages can lead to the development of end-stage liver diseases such as cirrhosis and hepatocellular carcinoma in severe cases, jeopardizing long-term quality of life, with a poor prognosis, and placing a serious financial burden on many families around the world. The pathogenesis of the disease is complex and closely related to the immune function of the body, which has not yet been fully elucidated. The development of chronic hepatitis B is closely related to the involvement of various signaling pathways, such as JAK/STAT, PI3K/Akt, Toll-like receptor, NF-κB and MAPK signaling pathways. A large number of studies have shown that Chinese medicine has obvious advantages in anti-hepatitis B virus, and it can effectively treat the disease by modulating relevant signaling pathways, strengthening immune resistance and defense, and inhibiting inflammatory responses, and certain research progress has been made, but there is still a lack of a comprehensive review on the modulation of relevant signaling pathways in Chinese medicine for the treatment of CHB. Therefore, this article systematically combed and elaborated the relevant literature on the modulation of relevant signaling pathways by traditional Chinese medicine in recent years, with a view to providing new ideas for the treatment of CHB and further drug development.